Seeking Alpha EN

TELA Bio GAAP EPS of -$0.17 beats by $0.01, revenue of $20.9M misses by $0.14M

Mar 24, 2026 &03222424202631; 20:22 UTC seekingalpha.com Trending 2/5

Read original on seekingalpha.com ↗

↘

Negative for markets

Sentiment score: -35/100

Moderate impact Short-term (days)

WHAT THIS MEANS

TELA Bio reported Q3 GAAP EPS of -$0.17 (beat by $0.01) but revenue of $20.9M missed expectations by $0.14M. Fresh earnings miss on topline with modest EPS beat suggests weak operational momentum despite cost control.

AI CONFIDENCE

62% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

TELA

TELAStock

Expected to decline

Revenue miss (-$0.14M) is the primary driver; EPS beat is marginal and likely reflects cost-cutting rather than operational strength. Biotech/medtech stocks are sensitive to revenue misses in current risk-off environment (VIX +3.25%, S&P -0.37%). Fresh catalyst with no prior market reaction.

⇅

S&P 500

^GSPCIndex

High volatility expected

Broader market weakness (S&P -0.37%, VIX elevated at 27) suggests risk-off sentiment; individual biotech miss adds to sector pressure but not a systemic catalyst.

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Short TELA on revenue miss with 2-3% downside target. Avoid if stock already down >1.5% at open; set stop at +2% above entry. Monitor broader biotech sector (XBI, IBB) for contagion risk. [MOVE:2.5%]

KEY SIGNALS

Revenue miss on fresh earnings (3 min old)EPS beat insufficient to offset topline weaknessVIX elevated, risk-off environment favors sellersBiotech sector under pressure

SECTORS INVOLVED

HealthcareBiotechnologyMedical Devices

Analysis generated on Mar 24, 2026 at 20:25 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

TELA Bio GAAP EPS of -$0.17 beats by $0.01, revenue of $20.9M misses by $0.14M

RELATED INTELLIGENCE